Literature DB >> 15203099

Polycystic kidney disease: new understanding in the pathogenesis.

Patricia D Wilson1.   

Abstract

Polycystic kidney disease (PKD) is a disease of the nephron, characterized by the formation of multiple renal tubular cysts, leading to endstage renal failure. The most common form is autosomal dominant PKD (ADPKD) and is caused by mutations in the PKD1 gene in 85% of cases or in PKD2 in 10-15%. Rarer forms include autosomal recessive PKD (ARPKD) and nephronophthisis with high mortality and morbidity in children. Recent advances suggest that the PKD1-encoded protein, polycystin-1, is a renal epithelial cell membrane mechanoreceptor, sensing morphogenetic cues in the extracellular environment at the basal surface in focal adhesion complexes; at the lateral surface in cell adherens junctions; and in the lumen at the apical primary cilium. Activation via multiprotein complex formation, intracellular signal transduction cascades and regulation of fetal gene transcription leads to appropriate renal tubule epithelial cell division and differentiation in normal kidneys, but is disrupted in PKD resulting in cyst formation.

Entities:  

Mesh:

Year:  2004        PMID: 15203099     DOI: 10.1016/j.biocel.2004.03.012

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  50 in total

Review 1.  Planar cell polarity in kidney development and disease.

Authors:  Thomas J Carroll; Amrita Das
Journal:  Organogenesis       Date:  2011-07-01       Impact factor: 2.500

2.  Loss of PKD1 and loss of Bcl-2 elicit polycystic kidney disease through distinct mechanisms.

Authors:  P Hughes; M Robati; W Lu; J Zhou; A Strasser; P Bouillet
Journal:  Cell Death Differ       Date:  2005-11-11       Impact factor: 15.828

3.  The C-terminal tail of the polycystin-1 protein interacts with the Na,K-ATPase alpha-subunit.

Authors:  Alessandra Zatti; Veronique Chauvet; Vanathy Rajendran; Thoru Kimura; Phillip Pagel; Michael J Caplan
Journal:  Mol Biol Cell       Date:  2005-08-17       Impact factor: 4.138

4.  Src inhibition ameliorates polycystic kidney disease.

Authors:  William E Sweeney; Rodo O von Vigier; Philip Frost; Ellis D Avner
Journal:  J Am Soc Nephrol       Date:  2008-04-02       Impact factor: 10.121

Review 5.  Heterotrimeric G protein signaling in polycystic kidney disease.

Authors:  Taketsugu Hama; Frank Park
Journal:  Physiol Genomics       Date:  2016-05-13       Impact factor: 3.107

6.  Update on vascular endothelial Ca(2+) signalling: A tale of ion channels, pumps and transporters.

Authors:  Francesco Moccia; Roberto Berra-Romani; Franco Tanzi
Journal:  World J Biol Chem       Date:  2012-07-26

7.  Hepatic cystogenesis is associated with abnormal expression and location of ion transporters and water channels in an animal model of autosomal recessive polycystic kidney disease.

Authors:  Jesús M Banales; Tatyana V Masyuk; Pamela S Bogert; Bing Q Huang; Sergio A Gradilone; Seung-Ok Lee; Angela J Stroope; Anatoliy I Masyuk; Juan F Medina; Nicholas F LaRusso
Journal:  Am J Pathol       Date:  2008-11-06       Impact factor: 4.307

8.  Carboxy terminal tail of polycystin-1 regulates localization of TSC2 to repress mTOR.

Authors:  Ruhee Dere; Patricia D Wilson; Richard N Sandford; Cheryl Lyn Walker
Journal:  PLoS One       Date:  2010-02-16       Impact factor: 3.240

Review 9.  Polycystic kidney diseases: from molecular discoveries to targeted therapeutic strategies.

Authors:  O Ibraghimov-Beskrovnaya; N Bukanov
Journal:  Cell Mol Life Sci       Date:  2008-02       Impact factor: 9.261

10.  Naturally occurring mutations alter the stability of polycystin-1 polycystic kidney disease (PKD) domains.

Authors:  Liang Ma; Meixiang Xu; Julia R Forman; Jane Clarke; Andres F Oberhauser
Journal:  J Biol Chem       Date:  2009-09-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.